Evaluation of Ischemic Modified Albumin Levels in Coronavirus Disease 2019-Positive and -Negative Patients with Acute Cardiac Injury.
Journal
Anatolian journal of cardiology
ISSN: 2149-2271
Titre abrégé: Anatol J Cardiol
Pays: Turkey
ID NLM: 101652981
Informations de publication
Date de publication:
01 12 2023
01 12 2023
Historique:
medline:
5
12
2023
pubmed:
7
10
2023
entrez:
7
10
2023
Statut:
ppublish
Résumé
The severe acute respiratory syndrome coronavirus 2 is the source of the global pandemic known as coronavirus disease 2019, and the disease prognosis is also linked to the prevalence of cardiac problems. In our study, we aimed to contribute to the early diagnosis and treatment of cardiac complications by evaluating ischemic modified albumin levels in adults with coronavirus disease 2019 disease. Our study was conducted with a total of 176 cases: group 1 (n = 70) with cardiac injury and coronavirus disease 2019 (+), group 2 (n = 57) with cardiac injury and coronavirus disease (-), and group 3 (n = 49) with healthy volunteers. The Mann-Whitney U test, the average, SD, minimum and maximum values, intergroup comparison of the results, and statistical significance were evaluated with the Pearson correlation coefficient. As a result of the bilateral comparisons, ischemic modified albumin measurements of the coronavirus disease 2019 (+) and coronavirus disease 2019 (-) groups were higher than the control group (P =.006 and P =.006, respectively). There was no statistically significant difference between ischemic modified albumin measurements of coronavirus disease 2019 (+) and coronavirus disease 2019 (-) groups. Ischemic modified albumin measurement accelerates the diagnosis and treatment process in the evaluation of cardiac injuries in coronavirus disease 2019 patients.
Sections du résumé
BACKGROUND
The severe acute respiratory syndrome coronavirus 2 is the source of the global pandemic known as coronavirus disease 2019, and the disease prognosis is also linked to the prevalence of cardiac problems. In our study, we aimed to contribute to the early diagnosis and treatment of cardiac complications by evaluating ischemic modified albumin levels in adults with coronavirus disease 2019 disease.
METHODS
Our study was conducted with a total of 176 cases: group 1 (n = 70) with cardiac injury and coronavirus disease 2019 (+), group 2 (n = 57) with cardiac injury and coronavirus disease (-), and group 3 (n = 49) with healthy volunteers. The Mann-Whitney U test, the average, SD, minimum and maximum values, intergroup comparison of the results, and statistical significance were evaluated with the Pearson correlation coefficient.
RESULTS
As a result of the bilateral comparisons, ischemic modified albumin measurements of the coronavirus disease 2019 (+) and coronavirus disease 2019 (-) groups were higher than the control group (P =.006 and P =.006, respectively). There was no statistically significant difference between ischemic modified albumin measurements of coronavirus disease 2019 (+) and coronavirus disease 2019 (-) groups.
CONCLUSION
Ischemic modified albumin measurement accelerates the diagnosis and treatment process in the evaluation of cardiac injuries in coronavirus disease 2019 patients.
Identifiants
pubmed: 37804148
doi: 10.14744/AnatolJCardiol.2023.3431
pmc: PMC10698386
doi:
Substances chimiques
Albumins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
706-711Références
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
Clin Chem Lab Med. 2012 Feb 14;50(8):1417-21
pubmed: 22868807
Am J Clin Pathol. 2005 Jan;123(1):140-5
pubmed: 15762290
Eur Heart J. 2007 May;28(10):1205-10
pubmed: 17440221
Am J Emerg Med. 2011 Jul;29(6):675-81
pubmed: 20825881
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Clin Chem Lab Med. 2011 Feb;49(2):177-84
pubmed: 21083441
CMAJ. 2005 Jun 21;172(13):1685-90
pubmed: 15967971
Pak J Med Sci. 2013 Jul;29(4):1003-7
pubmed: 24353676
Heart Vessels. 2008 May;23(3):174-80
pubmed: 18484160
Circulation. 2001 Apr 3;103(13):1718-20
pubmed: 11282900
Eur Heart J. 2017 Feb 1;38(5):334-337
pubmed: 27856498
N Engl J Med. 2018 Jan 25;378(4):345-353
pubmed: 29365305
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Endocrinol Invest. 2014 Sep;37(9):819-27
pubmed: 24957167
Indian J Clin Biochem. 2006 Mar;21(1):77-82
pubmed: 23105573
Drug Metab Pharmacokinet. 2009;24(4):333-41
pubmed: 19745560
J Am Coll Cardiol. 2020 May 12;75(18):2372-2375
pubmed: 32199938
PLoS One. 2022 Jul 26;17(7):e0271882
pubmed: 35881574
J Pharm Biomed Anal. 2014 Mar;91:17-23
pubmed: 24434278
Eur Heart J. 2021 Jan 7;42(2):206
pubmed: 32176300